Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias.
<h4>Background</h4>Moderately elevated blood levels of homocysteine are weakly correlated with coronary heart disease (CHD) risk, but causality remains uncertain. When folate levels are low, the TT genotype of the common C677T polymorphism (rs1801133) of the methylene tetrahydrofolate re...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/7f5a426f397543f1857ef493ad0d882a |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:7f5a426f397543f1857ef493ad0d882a |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:7f5a426f397543f1857ef493ad0d882a2021-11-18T05:42:21ZHomocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias.1549-12771549-167610.1371/journal.pmed.1001177https://doaj.org/article/7f5a426f397543f1857ef493ad0d882a2012-02-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22363213/?tool=EBIhttps://doaj.org/toc/1549-1277https://doaj.org/toc/1549-1676<h4>Background</h4>Moderately elevated blood levels of homocysteine are weakly correlated with coronary heart disease (CHD) risk, but causality remains uncertain. When folate levels are low, the TT genotype of the common C677T polymorphism (rs1801133) of the methylene tetrahydrofolate reductase gene (MTHFR) appreciably increases homocysteine levels, so "Mendelian randomization" studies using this variant as an instrumental variable could help test causality.<h4>Methods and findings</h4>Nineteen unpublished datasets were obtained (total 48,175 CHD cases and 67,961 controls) in which multiple genetic variants had been measured, including MTHFR C677T. These datasets did not include measurements of blood homocysteine, but homocysteine levels would be expected to be about 20% higher with TT than with CC genotype in the populations studied. In meta-analyses of these unpublished datasets, the case-control CHD odds ratio (OR) and 95% CI comparing TT versus CC homozygotes was 1.02 (0.98-1.07; p = 0.28) overall, and 1.01 (0.95-1.07) in unsupplemented low-folate populations. By contrast, in a slightly updated meta-analysis of the 86 published studies (28,617 CHD cases and 41,857 controls), the OR was 1.15 (1.09-1.21), significantly discrepant (p = 0.001) with the OR in the unpublished datasets. Within the meta-analysis of published studies, the OR was 1.12 (1.04-1.21) in the 14 larger studies (those with variance of log OR<0.05; total 13,119 cases) and 1.18 (1.09-1.28) in the 72 smaller ones (total 15,498 cases).<h4>Conclusions</h4>The CI for the overall result from large unpublished datasets shows lifelong moderate homocysteine elevation has little or no effect on CHD. The discrepant overall result from previously published studies reflects publication bias or methodological problems.Robert ClarkeDerrick A BennettSarah ParishPetra VerhoefMariska Dötsch-KlerkMark LathropPeng XuBørge G NordestgaardHilma HolmJemma C HopewellDanish SaleheenToshihiro TanakaSonia S AnandJohn C ChambersMarcus E KleberWillem H OuwehandYoshiji YamadaClara ElbersBas PetersAlexandre F R StewartMuredach M ReillyBarbara ThorandSalim YusufJames C EngertThemistocles L AssimesJaspal KoonerJohn DaneshHugh WatkinsNilesh J SamaniRory CollinsRichard PetoMTHFR Studies Collaborative GroupPublic Library of Science (PLoS)articleMedicineRENPLoS Medicine, Vol 9, Iss 2, p e1001177 (2012) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R |
| spellingShingle |
Medicine R Robert Clarke Derrick A Bennett Sarah Parish Petra Verhoef Mariska Dötsch-Klerk Mark Lathrop Peng Xu Børge G Nordestgaard Hilma Holm Jemma C Hopewell Danish Saleheen Toshihiro Tanaka Sonia S Anand John C Chambers Marcus E Kleber Willem H Ouwehand Yoshiji Yamada Clara Elbers Bas Peters Alexandre F R Stewart Muredach M Reilly Barbara Thorand Salim Yusuf James C Engert Themistocles L Assimes Jaspal Kooner John Danesh Hugh Watkins Nilesh J Samani Rory Collins Richard Peto MTHFR Studies Collaborative Group Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. |
| description |
<h4>Background</h4>Moderately elevated blood levels of homocysteine are weakly correlated with coronary heart disease (CHD) risk, but causality remains uncertain. When folate levels are low, the TT genotype of the common C677T polymorphism (rs1801133) of the methylene tetrahydrofolate reductase gene (MTHFR) appreciably increases homocysteine levels, so "Mendelian randomization" studies using this variant as an instrumental variable could help test causality.<h4>Methods and findings</h4>Nineteen unpublished datasets were obtained (total 48,175 CHD cases and 67,961 controls) in which multiple genetic variants had been measured, including MTHFR C677T. These datasets did not include measurements of blood homocysteine, but homocysteine levels would be expected to be about 20% higher with TT than with CC genotype in the populations studied. In meta-analyses of these unpublished datasets, the case-control CHD odds ratio (OR) and 95% CI comparing TT versus CC homozygotes was 1.02 (0.98-1.07; p = 0.28) overall, and 1.01 (0.95-1.07) in unsupplemented low-folate populations. By contrast, in a slightly updated meta-analysis of the 86 published studies (28,617 CHD cases and 41,857 controls), the OR was 1.15 (1.09-1.21), significantly discrepant (p = 0.001) with the OR in the unpublished datasets. Within the meta-analysis of published studies, the OR was 1.12 (1.04-1.21) in the 14 larger studies (those with variance of log OR<0.05; total 13,119 cases) and 1.18 (1.09-1.28) in the 72 smaller ones (total 15,498 cases).<h4>Conclusions</h4>The CI for the overall result from large unpublished datasets shows lifelong moderate homocysteine elevation has little or no effect on CHD. The discrepant overall result from previously published studies reflects publication bias or methodological problems. |
| format |
article |
| author |
Robert Clarke Derrick A Bennett Sarah Parish Petra Verhoef Mariska Dötsch-Klerk Mark Lathrop Peng Xu Børge G Nordestgaard Hilma Holm Jemma C Hopewell Danish Saleheen Toshihiro Tanaka Sonia S Anand John C Chambers Marcus E Kleber Willem H Ouwehand Yoshiji Yamada Clara Elbers Bas Peters Alexandre F R Stewart Muredach M Reilly Barbara Thorand Salim Yusuf James C Engert Themistocles L Assimes Jaspal Kooner John Danesh Hugh Watkins Nilesh J Samani Rory Collins Richard Peto MTHFR Studies Collaborative Group |
| author_facet |
Robert Clarke Derrick A Bennett Sarah Parish Petra Verhoef Mariska Dötsch-Klerk Mark Lathrop Peng Xu Børge G Nordestgaard Hilma Holm Jemma C Hopewell Danish Saleheen Toshihiro Tanaka Sonia S Anand John C Chambers Marcus E Kleber Willem H Ouwehand Yoshiji Yamada Clara Elbers Bas Peters Alexandre F R Stewart Muredach M Reilly Barbara Thorand Salim Yusuf James C Engert Themistocles L Assimes Jaspal Kooner John Danesh Hugh Watkins Nilesh J Samani Rory Collins Richard Peto MTHFR Studies Collaborative Group |
| author_sort |
Robert Clarke |
| title |
Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. |
| title_short |
Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. |
| title_full |
Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. |
| title_fullStr |
Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. |
| title_full_unstemmed |
Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. |
| title_sort |
homocysteine and coronary heart disease: meta-analysis of mthfr case-control studies, avoiding publication bias. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2012 |
| url |
https://doaj.org/article/7f5a426f397543f1857ef493ad0d882a |
| work_keys_str_mv |
AT robertclarke homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT derrickabennett homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT sarahparish homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT petraverhoef homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT mariskadotschklerk homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT marklathrop homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT pengxu homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT børgegnordestgaard homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT hilmaholm homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT jemmachopewell homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT danishsaleheen homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT toshihirotanaka homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT soniasanand homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT johncchambers homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT marcusekleber homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT willemhouwehand homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT yoshijiyamada homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT claraelbers homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT baspeters homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT alexandrefrstewart homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT muredachmreilly homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT barbarathorand homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT salimyusuf homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT jamescengert homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT themistocleslassimes homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT jaspalkooner homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT johndanesh homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT hughwatkins homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT nileshjsamani homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT rorycollins homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT richardpeto homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias AT mthfrstudiescollaborativegroup homocysteineandcoronaryheartdiseasemetaanalysisofmthfrcasecontrolstudiesavoidingpublicationbias |
| _version_ |
1718424796522348544 |